Chong Boon Teo
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
-
- Olfactory and Sensory Function Studies 2
- Co-authors
- Benjamin Kye Jyn Tan (11 shared papers)Raghav Sundar (8 shared papers)Yiong Huak Chan (4 shared papers)Yu Yang Soon (3 shared papers)Mark Dhinesh Muthiah (1 shared paper)Shi Yin Wong (1 shared paper)Matilda Xinwei Lee (1 shared paper)Sen Hee Tay (1 shared paper)
- Journals
- Gastric Cancer (2 papers)BMJ (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)
- Partner nations
- SingaporeAustraliaUnited States
In The Last Decade
Chong Boon Teo
20 papers receiving 795 citations
Chong Boon Teo's Hit Papers
Peers
Comparison fields: 5 of 89
- Infectious Diseases 255
- Oncology 188
- Gastroenterology 28
- Health Informatics 8
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by Chong Boon Teo
This map shows the geographic impact of Chong Boon Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Boon Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Boon Teo more than expected).
Fields of papers citing papers by Chong Boon Teo
This network shows the impact of papers produced by Chong Boon Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Boon Teo. The network helps show where Chong Boon Teo may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong Boon Teo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis Hit paper breakdown → | 2022 | 348 |
| 2 | 2021 | 136 | |
| 3 | 2022 | 89 | |
| 4 | 2024 | 35 | |
| 5 | 2021 | 31 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 18 | |
| 8 | 2023 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2024 | 16 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2025 | 9 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 2 |
About Chong Boon Teo
Chong Boon Teo is a scholar working on Oncology, Sensory Systems, Cancer Research, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 802 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Olfactory and Sensory Function Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Electrolyte and hormonal disorders (2 papers), Obstructive Sleep Apnea Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Infectious Diseases (255 citations), Oncology (188 citations), Gastroenterology (28 citations), Health Informatics (8 citations) and Pulmonary and Respiratory Medicine (123 citations). Chong Boon Teo has collaborated with scholars based in Singapore, Australia and United States. Frequent co-authors include Benjamin Kye Jyn Tan, Raghav Sundar, Yiong Huak Chan, Yu Yang Soon, Mark Dhinesh Muthiah, Shi Yin Wong, Matilda Xinwei Lee, Sen Hee Tay, Louis Yi Ann Chai and Soo Chin Lee. Their work appears in journals such as Gastric Cancer, BMJ, The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.